H-1B Filings
15
Major sponsor. DOL labor condition applications on file.
Professional & Technical Services MA DOL H-1B OSHA ITA
CRISPR Therapeutics, Inc.: H-1B Sponsorship Profile
CRISPR Therapeutics, Inc. in MA (Professional & Technical Services) is a sponsorship-and-safety profile: 15 H-1B LCAs plus an employer-specific OSHA injury record, with no WARN notices in this corpus.
CRISPR Therapeutics, Inc. (MA): · 15 H-1B LCAs at a $121,919 disclosed median · OSHA Grade A (DART 0.00)
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, CRISPR Therapeutics, Inc. in MA carries 15 H-1B wage filings on record, a $121,919 median wage across 13 disclosed-wage positions (below the $124,488 national median), a strong A OSHA safety grade and no WARN layoff notices on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
- 15 H-1B LCAs
- $121,919 median wage
- Grade A OSHA
The record at a glance
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #3,441 of 51,370 sponsors in this corpus (about the 93rd percentile), and disclosed median wage sits at the 48th percentile of 272,125 credible H-1B wage rows.
- 93rd pct
- H-1B filing rank
- 48th pct
- median wage rank
- 63%
- safer on DART than
- 14%
- cleaner WARN history than
Figures above come from DOL H-1B LCAs and this employer's OSHA injury log; no WARN notices are on file here.
C-
Federal workforce composite
52/100
4 of 4 federal tracks · CRISPR Therapeutics, Inc.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Sponsorship scale A+
15 H-1B LCAs
#3,441 of 51,370 sponsors · 93rd percentile by volume (DOL OFLC)
Disclosed pay D
$121,919 median
48th percentile of 272,125 credible H-1B wage rows
Workplace safety C+
OSHA Grade A · DART 0.00
Safer than 63% of 214,554 employers with an OSHA ITA record
Layoff stability F
0 WARN notices
Cleaner WARN history than 14% of 304,376 tracked employers (state workforce agencies)
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
Median H-1B Salary
$121,919
Near national median. Across 13 disclosed positions
OSHA Safety Grade
Grade A · DART 0.00
Safer than industry average. vs 0.27 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
Where CRISPR Therapeutics, Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$121,919 Top 52% higher than 48% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
CRISPR Therapeutics, Inc.'s H-1B median wage, FY2024 vs FY2025
Filing-count-weighted median across this employer's own disclosed H-1B positions (+1.8% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
Government Data Summary
| Field | Value | Source |
|---|---|---|
| Employer Name | CRISPR Therapeutics, Inc. | DOL OFLC / OSHA |
| Industry | Professional & Technical Services | NAICS / DOL |
| State | MA | U.S. Federal Records |
| H-1B Filings | 15 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $121,919 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | A | OSHA ITA |
| OSHA DART Rate | 0.00 | OSHA ITA Establishment Records |
| Tracks not on file | WARN notices | Empty by design, not estimated |
CRISPR Therapeutics, Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records on file for this employer in MA (Professional & Technical Services). In this corpus, H-1B filing volume ranks #3,441 of 51,370 sponsors in this corpus (about the 93rd percentile); disclosed median wage sits at the 48th percentile of 272,125 credible H-1B wage rows; OSHA DART rate is safer than roughly 63% of 214,554 employers with an establishment injury record.
H-1B Salary Data
| Job Title | Median |
|---|---|
| Senior Medical Director, Pharmacovigilance | $320,000 |
| Global Regulatory Lead, Director, Regulatory Affairs | $235,000 |
| Associate Director, Regulatory Affairs | $195,000 |
| Associate Director, Program Management | $182,183 |
| Senior Manager, IT Business Applications (G&A) | $154,397 |
| Associate Clinical Trial Manager | $124,919 |
| Principal Research Associate | $121,919 |
| Senior Research Associate | $117,915 |
| Senior Bioinformatics Engineer | $116,150 |
| Senior Quality Control Stability Specialist | $115,000 |
| Senior Research Associate | $103,770 |
| Senior Research Associate, Translational Biology | $102,000 |
| Research Associate II | $90,397 |
| Manager, Regulatory Affairs | N/A |
What the Data Says About CRISPR Therapeutics, Inc.
Signature stat: H-1B volume
CRISPR Therapeutics, Inc.'s most extreme placement is sponsorship scale: 15 H-1B LCAs rank higher than 93% of sponsors in this corpus (#3,441 of 51,370).
Safety near sector average
DART 0 tracks close to the 0.3 sector average (Grade A).
Growing LCA footprint
FY2025 added 2 filings versus FY2024 (66.7%), a sponsorship expansion visible in the raw LCA counts.
No WARN filings
No WARN Act mass-layoff notices are on file for CRISPR Therapeutics, Inc. among Professional & Technical Services employers we track.
Typical disclosed pay
A $121,919 disclosed median lands near the middle of the wage distribution (48th percentile vs $124,488 nationally).
Where CRISPR Therapeutics, Inc. sits
This employer among Professional & Technical Services H-1B peers
Across the 200 Professional & Technical Services sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, CRISPR Therapeutics, Inc. files more petitions than 0% of them and discloses a higher median wage than 51%, the selective, above-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (15 filings · $121,919 median here).
Each muted dot is one professional & technical services peer from a filings-stratified sample of 42; the brand marker is CRISPR Therapeutics, Inc.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
How CRISPR Therapeutics, Inc. compares to Professional & Technical Services peers
CRISPR Therapeutics, Inc.'s nearest H-1B-filing peers in Professional & Technical Services (home state MA). Each card links to that employer's federal-records profile.
CRISPR Therapeutics, Inc.
15 H-1B filings
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
8,624 H-1B filings
Google LLC
5,397 H-1B filings
What to check before working with CRISPR Therapeutics, Inc.
For CRISPR Therapeutics, Inc., read sponsorship pay (15 H-1B LCAs, median $121,919) next to the OSHA safety grade (A).
- H-1B median is $121,919 across 13 disclosed-wage positions (of 15 total filings), benchmark any offer against it and the metro prevailing wage. Compare with peers
- Safety grade A reflects a DART rate read against the Professional & Technical Services average of 0.27 - a relative benchmark, not an absolute verdict. How grades work
CRISPR Therapeutics, Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Read with this employer
- COGNIZANT TECHNOLOGY SOLUTIONS US CORP (TX) - 8,624 H-1B filings in the same Professional & Technical Services roster
- Google LLC (CA) - 5,397 H-1B filings in the same Professional & Technical Services roster
- INFOSYS LIMITED (TX) - 5,329 H-1B filings in the same Professional & Technical Services roster
- Interpreting safety grades - how CRISPR Therapeutics, Inc.'s OSHA DART read is graded against its sector.
- H-1B salary negotiation - using disclosed wages like CRISPR Therapeutics, Inc.'s when you negotiate.
- Compare employers - put CRISPR Therapeutics, Inc. next to peers on pay, safety, and WARN.
- National H-1B & safety statistics - where CRISPR Therapeutics, Inc.'s #3,441 placement sits in the full federal roster.
Retrieved and formatted by PlainEmployers.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Frequently Asked Questions
Where does CRISPR Therapeutics, Inc.'s H-1B wage sit nationally?
Among 272,125 credible H-1B wage rows in this corpus, CRISPR Therapeutics, Inc.'s disclosed median of $121,919 sits at the 48th percentile (below the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
How does CRISPR Therapeutics, Inc.'s H-1B filing volume compare to other sponsors?
CRISPR Therapeutics, Inc. has 15 H-1B filings on record, ranking #3,441 of 51,370 sponsors in this corpus (about the 93rd percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
What does CRISPR Therapeutics, Inc.'s OSHA safety grade mean?
CRISPR Therapeutics, Inc. carries Grade A from its establishment injury record (0 injuries on file; DART 0.00). That DART rate is safer than roughly 63% of 214,554 employers with an injury record in this corpus. Grades compare DART against industry averages, see the Interpreting Safety Grades guide.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and OSHA Injury Tracking Application records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.